Physician

Matthew Kliethermes, M.D.

According to 2025 Medicare claims, Matthew Kliethermes, M.D. (NPI: 1417303363) practices ophthalmology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is VISALIA EYE CENTER, INC. (NPI: 1770527335; TIN: 731728125) and primary practice location at 93291-5121.

Kliethermes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 986 traditional Medicare patients, billed 9,400 HCPCS/CPT codes, and received $608,947 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,462 prescription claims across 522 beneficiaries totaling $195,866 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 20 records totaling $503. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $68,198 to $608,947. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,564 to $195,866. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$304K$609K2019 Medicare payment: $68,198 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $220,230 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $274,662 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $322,694 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $528,061 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $608,947 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019307727$68,198
20206712,330$220,230
20217172,262$274,662
20228682,894$322,694
20238765,683$528,061
20249869,400$608,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$135K$270K2019 Drug cost: $15,564 (USD; Tot_Drug_Cst)2020 Drug cost: $72,270 (USD; Tot_Drug_Cst)2021 Drug cost: $132,076 (USD; Tot_Drug_Cst)2022 Drug cost: $195,296 (USD; Tot_Drug_Cst)2023 Drug cost: $269,730 (USD; Tot_Drug_Cst)2024 Drug cost: $195,866 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019100234$15,564
20203141,183$72,270
20214201,962$132,076
20225172,607$195,296
20235912,948$269,730
20245222,462$195,866

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system470476$87
92012Established patient problem focused exam of visual system585887$62
92083Exam of visual field with extended testing199208$45
92134Imaging of retina210449$31
92133Imaging of optic nerve176180$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine662,745$52,604
RhopressaNetarsudil Mesylate812,725$30,542
LumiganBimatoprost321,506$15,162
Lotemax SmLoteprednol Etabonate411,493$10,200
CyclosporineCyclosporine211,065$8,933

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$503Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Kliethermes, M.D.?

Tedicare shows public-source Medicare data for Matthew Kliethermes, M.D. (NPI 1417303363), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Kliethermes, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Kliethermes, M.D.?

Matthew Kliethermes, M.D. is linked to VISALIA EYE CENTER, INC. (billing NPI 1770527335) in the available physician profile data.

Does Matthew Kliethermes, M.D. have Open Payments data?

Matthew Kliethermes, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.